Clinicopathological Features and Prognostic Role of HER2 Low in Early Breast Cancer: A real world study

被引：0
|
作者：
Kong, Ziqing
Zhao, Weihong
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 09期
关键词：
D O I：
10.1158/1538-7445.SABCS23-PO2-02-07
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PO2-02-07
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Clinicopathological features of HR+/HER2 low breast cancer in a real-world setting in China
    Min, Z.
    Zhou, F.
    Qu, H.
    Ren, Y.
    Liang, W.
    Liu, M.
    Wang, J.
    Luo, J.
    Tan, X.
    Dai, G.
    Hu, G.
    Meng, Q.
    He, W.
    Wang, H.
    Liu, W.
    Tang, H.
    Wu, Q.
    Liu, H.
    Tian, Y.
    Qin, Z.
    ANNALS OF ONCOLOGY, 2024, 35 : S1412 - S1412
  • [2] Clinicopathological features and prognostic analysis of HER2 low and fibrotic focus in HER2-negative breast cancer
    Yue, Meng
    Wu, Si
    Liu, Chang
    Cai, Lijing
    Wang, Xinran
    Jia, Ying
    Han, Dandan
    Liu, Yueping
    BREAST CANCER RESEARCH AND TREATMENT, 2024, 203 (02) : 373 - 381
  • [3] Clinicopathological features and prognostic analysis of HER2 low and fibrotic focus in HER2-negative breast cancer
    Meng Yue
    Si Wu
    Chang Liu
    Lijing Cai
    Xinran Wang
    Ying Jia
    Dandan Han
    Yueping Liu
    Breast Cancer Research and Treatment, 2024, 203 : 373 - 381
  • [4] Clinicopathological Features and Prognostic Significance of HER2 Expression in Gastric Cancer
    Park, Ji Soo
    Rha, Sun Young
    Chung, Hyun Cheol
    Jung, Minkyu
    Kim, Ki Hyang
    Jun, Hyun Jung
    Kim, Hyunki
    An, Ji Yeong
    Kim, Hyoung-Il
    Cheong, Jae-Ho
    Hyung, Woo Jin
    Noh, Sung Hoon
    Kim, Hyo Song
    ONCOLOGY, 2015, 88 (03) : 147 - 156
  • [5] STUDY OF EXPRESSION OF HER2/NEU IN CARCINOMA BREAST WITH REFERENCE TO CLINICOPATHOLOGICAL FEATURES AND PROGNOSTIC INDEX
    Josephin, Jeena J. R.
    Babu, Suresh K.
    JOURNAL OF EVOLUTION OF MEDICAL AND DENTAL SCIENCES-JEMDS, 2016, 5 (90): : 6726 - 6732
  • [6] Prognostic difference between early breast cancer patients with HER2 low and HER2 zero status
    Cha, Chihwan David
    Kim, Kyung Eun
    Kim, Jungbin
    Um, Eunhae
    Choi, Nayeon
    Lee, Jungsun
    Gwak, Geumhee
    Kim, Jae Il
    Chung, Min Sung
    NPJ BREAST CANCER, 2025, 11 (01)
  • [7] The emerging predictive and prognostic role of HER2 in HER2-negative early breast cancer: a retrospective study
    Coriano, Matilde
    Tommasi, Chiara
    Dinh, Anh Thi Lan
    Needham, Jazmine
    Aziz, Hala
    Joharatnam-Hogan, Nalinie
    Cunningham, Niamh
    Waterhouse, Jasmin
    Sun, Mingze
    Turkes, Fiona
    Pellegrino, Benedetta
    Mcgrath, Sophie
    Okines, Alicia
    Parton, Marina
    Turner, Nicholas
    Johnston, Stephen
    Musolino, Antonino
    Ring, Alistair
    Battisti, Nicolo Matteo Luca
    BREAST CANCER RESEARCH AND TREATMENT, 2024, 206 (03) : 603 - 614
  • [8] Prognostic values of clinical and molecular features in HER2 low-breast cancer with hormonal receptor overexpression: features of HER2-low breast cancer
    Mengdi Chen
    Weilin Chen
    Deyue Liu
    Weiguo Chen
    Kunwei Shen
    Jiayi Wu
    Li Zhu
    Breast Cancer, 2022, 29 : 844 - 853
  • [9] Prognostic values of clinical and molecular features in HER2 low-breast cancer with hormonal receptor overexpression: features of HER2-low breast cancer
    Chen, Mengdi
    Chen, Weilin
    Liu, Deyue
    Chen, Weiguo
    Shen, Kunwei
    Wu, Jiayi
    Zhu, Li
    BREAST CANCER, 2022, 29 (05) : 844 - 853
  • [10] Real world evidence of adjuvant trastuzumab in HER2 positive early breast cancer
    Lluch-Gomez, J.
    Nunez-Alvarez, V.
    de la Torre-Hita, C.
    Bernal-Gomez, M.
    Campini-Bermejo, A.
    Perdomo-Zaldivar, E.
    Rodriguez-Perez, L.
    Calvete-Candenas, J.
    Martinez-Bautista, M. J.
    Benitez-Rodriguez, E.
    Baena-Canada, J. M.
    SCIENTIFIC REPORTS, 2023, 13 (01)
12345